ADVATx

As the world’s only solid-state laser producing both 589 nm and 1319 nm wavelengths, ADVATx has over 15 FDA/CE cleared indications including vascular conditions, acne, scars, warts and wrinkles.

A new generation of laser for the modern physician’s office

ADVATx is developed for physicians who are looking for the most advanced solutions for highly sought after treatments, without pain, downtime or expensive consumables.

16

FDA/CE cleared indications

15-30 min

Treatment Time

$0

Consumable Cost

SIMPLE USER INTERFACE

Usability is one of the fundamentals in the design of ADVATx. We have developed the user interface to be simple, intuitive and easy to operate.

SCANNER HAND PIECE

Single Spot or Fractionated Delivery – Both 589nm and 1319nm are delivered via the same scanner hand piece.

SCANNER PATTERNS

ADVATx scanner deliveries different scan patterns allowing the physician to tailor the delivery of laser energy according to the area being treated.

David J. Goldberg, M.D., J.D.

“The next generation replacement for the pulsed dye laser.”

Why chose ADVATx?

Better Patient Experience
  • Minimal downtime
  • Minimal discomfort
  • <trauma=drama>
Better Patient Outcomes
  • Off the table results
  • No oedema
  • No PIH
  • No crusting or peeling
  • No Purpura
Better Technology
  • More effective and safer than IPL
  • More versatile and safer than KTP (532 nm)
  • Unique combination of wavelengths
Better ROI
  • No consumables
  • low operating cost
  • 18 months warranty
  • in demand treatments

ADVATx-A Foundational Technology in Dermatolo Aesthetics

The ADVATx laser system was launched commercially in 2018

ADVATx is CE/FDA approved as medical equiptment suited for the treatment of 25 different skin conditions

It’s unique, patented laser technology makes the ADVATx highly versatile, clinically efficient, and very safe to use

Grow your practice with ADVATx

With 15 FDA/CE cleared indications ranging from wrinkles and skin rejuvenation to melasma and acne, it’s not uncommon for our physicians to treat 30 or more patients per month with the ADVATx.